Apheresis and intravenous immunoglobulins used in addition to conventional therapy to treat high-risk pregnant antiphospholipid antibody syndrome patients. A prospective study

Journal of Reproductive Immunology

Volumn 115, Issue , 2016, Pages 14-19

  Ruffatti, Amelia ^a   Favaro, Maria ^a   Hoxha, Ariela ^a   Zambon, Alessandra ^a   Marson, Piero ^b   Del Ross, Teresa ^a   Calligaro, Antonia ^a   Tonello, Marta ^a   Nardelli, Giovanni B ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Immunoadsorption; Intravenous immunoglobulins; Obstetric antiphospholipid syndrome; Plasmapheresis; Risk factors

Indexed keywords

CARDIOLIPIN ANTIBODY; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PHOSPHOLIPID ANTIBODY; PREDNISOLONE;

ABSENCE OF SIDE EFFECTS; ADULT; ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; APGAR SCORE; APHERESIS; ARTICLE; BIRTH WEIGHT; CASE STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FETUS HEART; GESTATIONAL AGE; HIGH RISK PREGNANCY; HUMAN; IMMUNOADSORPTION; LIVE BIRTH; LOW DRUG DOSE; LUNG SEQUESTRATION; MULTIPLE PREGNANCY; PLACENTA PREVIA; PLASMA VOLUME; PLASMAPHERESIS; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEPSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA; VESICOURETERAL REFLUX; EVALUATION STUDY; IMMUNOLOGY; PREGNANCY; PREGNANCY COMPLICATIONS; PROCEDURES; RISK; THROMBOSIS;

ADULT; ANTIPHOSPHOLIPID SYNDROME; BLOOD COMPONENT REMOVAL; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; RISK; THROMBOSIS;

EID: 84962920443     PISSN: 01650378     EISSN: 18727603     Source Type: Journal    
DOI: 10.1016/j.jri.2016.03.004     Document Type: Article

References (31)

1. Bontadi A., Ruffatti A., Marson P., Tison T., Tonello M., Hoxha A., et al. Plasma exchange and immunoadsorption effectively remove antiphospholipid antibodies in pregnant patients with antiphospholipid syndrome. J. Clin. Apher. 2012, 27:200-204.
2. Bortolati M., Marson P., Chiarelli S., Tison T., Facchinetti M., Gervasi M.T., et al. Case reports of the use of immunoadsorption or plasma exchange in high-risk pregnancies of women with antiphospholipid syndrome. Ther. Apher. Dial. 2009, 13:157-160.
3. Bramham K., Hunt B.J., Germain S., Calatayud I., Khamashta M., Bewley S., et al. Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome. Lupus 2010, 19:58-64.
4. Bramham K., Thomas M., Nelson-Piercy C., Khamashta M., Hunt B.J. First-trimester low-dose prednisolone in refractory antiphospholipid antibody-related pregnancy loss. Blood 2011, 117:6948-6951.
5. Branch D.W., Peaceman A.M., Druzin M., Silver R.K., El-Saied Y., Silver R.M., et al. A multicenter: placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The pregnancy loss study group. Am. J. Obstet. Gynecol. 2000, 182:122-127.
6. Cervera R., Rodríguez-Pintó I., Espinosa G. Catastrophic antiphospholipid syndrome: task force report summary. Lupus 2014, 23:1283-1285. on behalf of the Task Force on Catastrophic Antiphospholipid Syndrome.
7. Danowski A., de Azevedo M.N., de Souza Papi J.A., Petri M. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus. J. Rheumatol. 2009, 36:1195-1199.
8. El-Haieg D.O., Zanati M.F., El-Foual F.M. Plasmapheresis and pregnancy outcome in patients with antiphospholipid syndrome. Int. J. Gynaecol. Obstet. 2007, 99:236-241.
9. Empson M., Lassere M., Craig J.C., Scott J.R. Recurrent pregnancy loss with antiphospholipid antibodies: a systematic review therapeutic trials. Obstet. Gynecol. 2002, 99:135-144.
10. Fernandez-Jimenez M.C., Jimenez-Marco M.T., Hernandez D., Gonzalez A., Omenaca F., de la Camara C. Treatment with plasmapheresis and intravenous immunoglobulin in pregnancies complicated with anti-PP1Pk or anti-K immunization: a report of two patients. Vox Sang. 2001, 80:117-120.
11. Fischer-Betz R., Specker C., Brinks R., Schneider M. Pregnancy outcome in patients with antiphospholipid syndrome after cerebral ischaemic events: an observational study. Lupus 2012, 21:1183-1189.
12. Franklin R.D., Kutteh W.H. Antiphospholipid antibodies (APA) and recurrent pregnancy loss: a unique APA positive population. Hum. Reprod. 2002, 17:2981-2985.
13. Ibernon M., Gil-Vernet S., Carrera M., Seron D., Moreso F., Bestard O., et al. Therapy with plasmapheresis and intravenous immunoglobulin for acute humoral rejection in kidney transplantation. Transplant. Proc. 2005, 37:3743-3745.
14. Kaaja R., Julkunen H., Ammälä P., Palosuo T., Kurki P. Intravenous immunoglobulin treatment of pregnant patients with recurrent pregnancy losses associated with antiphospholipid antibodies. Acta Obstet. Gynecol. Scand. 1993, 72:63-66.
15. Kobayashi S., Tamura N., Tsuda H., Mokuno C., Hashimoto H., Hirose S. Immunoadsorbent plasmapheresis for a patient with antiphospholipid syndrome during pregnancy. Ann. Rheum. Dis. 1992, 51:399-401.
16. Kutteh W.H. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am. J. Obstet. Gynecol. 1996, 174:1584-1589.
17. Lockshin M.D., Kim M., Laskin C.A., Guerra M., Branch W.D., Merill J., et al. Lupus anticoagulant but not anticardiolipin antibody: predicts adverse pregnancy outcome in patients with antiphospholipid antibodies. Arthritis Rheum. 2012, 64:2311-2318.
18. Mak A., Cheung M.W., Cheak A.A., Ho R.C. Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression. Rheumatology 2010, 9:281-288.
19. Marson P., Bagatella P., Bortolati M., Tison T., De Silvestro G., Fabris F., et al. Plasma exchange for the management of the catastrophic antiphospholipid syndrome: importance of the type of fluid replacement. J. Intern. Med. 2008, 264:201-203.
20. Miyakis S., Lockshin M.D., Atsumi T., Branch D.V., Brey R.L., Cervera R., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J. Thromb. Haemost. 2006, 4:295-306.
21. Montgomery R.A., Zachary A.A., Racusen L.C., Leffell M.S., King K.E., Burdick J., et al. Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients. Transplantation 2000, 70:887-895.
22. Nakamura Y., Yoshida K., Itoh S., Kanay Y., Tsuda H., Hashimoto H., et al. Immunoadsorption plasmapheresis as a treatment for pregnancy complicated by systemic lupus erythematosus with positive antiphospholipid antibodies. Am. J. Reprod. Immunol. 1999, 41:307-311.
23. Pengo V., Tripodi A., Reber G., Rand J.H., Ortel T.L., Galli M., et al. Update of the guidelines for lupus anticoagulant detection. Subcommittee on lupus anticoagulant/antiphospholipid antibody of the scientific and standardisation committee of the international society on thrombosis and haemostasis. J. Thromb. Haemost. 2009, 7:1737-1740.
24. Rai R., Cohen H., Dave M., Regan L. Randomised controlled trial of aspirin and aspirin plus in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). Br. Med. J. 1997, 314:253-257.
25. Ruffatti A., Tonello M., Del Ross T., Cavazzana A., Grava C., Noventa F., et al. Antibody profile and clinical course in primari antiphospholipid syndrome with pregnancy morbidity. Thromb. Haemost. 2006, 96:337-341.
26. Ruffatti A., Marson P., Pengo V., Favaro M., Tonello M., Bortolati M., et al. Plasma exchange in the management of high risk pregnant patients with primary antiphospholipid syndrome. A report of 9 cases and a review of the literature. Autoimmun. Rev. 2007, 6:196-202.
27. Ruffatti A., Olivieri S., Tonello M., Bortolati M., Bison E., Salvan E., et al. Influence of different IgG anticardiolipin antibody cut-off values on antiphospholipid syndrome classification. J. Thromb. Haemost. 2008, 6:1693-1696.
28. Ruffatti A., Tonello M., Visentin M.S., Bontadi A., Hoxha A., De Carolis S., et al. Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study. Rheumatology 2011, 50:1684-1689.
29. Ruffatti A., Salvan E., Del Ross T., Gerosa M., Andreoli L., Maina A., et al. Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positività. A European multicentre retrospective study. Thromb. Haemost. 2014, 112:727-735.
30. Szodoray P., Bacskó G., Lakos G., Zeher M. Combined therapy in pregnancy with primary antiphospholipid syndrome. Orv. Hetil. 2003, 144:2411-2413.
31. Xiao J., Xiong J., Zhu F., He L. Effect of prednisone aspirin, low molecular weight heparin and intravenous immunoglobulin on outcome of pregnancy in women with antiphospholipid syndrome. Exp. Ther. Med. 2013, 5:287-291.